Molina Healthcare Inc. (MOH)

84.29
NYSE : Health Services
Prev Close 84.29
Day Low/High 0.00 / 0.00
52 Wk Low/High 56.67 / 93.98
Avg Volume 1.06M
Exchange NYSE
Shares Outstanding 61.69M
Market Cap 5.33B
EPS -9.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BP, BREW, BZUN, CHCT, CHS, MDT, MOH, PENN, SDPI, SHOP, TSCO, WP, ZX Downgrades: BMCH, LAWS, PBFX, SRT, TRI Initiations: PCSB Read on to get TheStreet Quant Ratings' detailed report:

Molina Healthcare To Host Investor Day Meeting

null

Accountability Adventure

Accountability Adventure

Assessing hits and misses in the last month.

How to Play Molina Health

How to Play Molina Health

Shares are finally reversing post-earnings slide in February.

Molina Healthcare Awarded Texas CHIP Contracts

Molina Healthcare Awarded Texas CHIP Contracts

Molina Healthcare, Inc. (NYSE: MOH) today announced that its Texas subsidiaries, Molina Healthcare of Texas, Inc.

Molina Healthcare Announces Pricing Of Synthetic Exchange Transaction

Molina Healthcare Announces Pricing Of Synthetic Exchange Transaction

Molina Healthcare, Inc. (NYSE: MOH) (the "Company") today announced that on March 5, 2018, it priced a synthetic exchange transaction with a limited number of holders (the "Noteholders") of its 1.

Molina Healthcare Announces Resignation Of John Molina From The Board Of Directors

Molina Healthcare Announces Resignation Of John Molina From The Board Of Directors

Molina Healthcare, Inc. (NYSE: MOH) today announced that John C.

TheStreet Quant Rating: B- (Buy)